# OnCo record rejuv-ayac-education-and-work (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/rejuv-ayac-education-and-work/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "rejuv-ayac-education-and-work" ;
  schema:name "Education, work and the years that were interrupted"@en ;
  schema:description "Cancer in the years when education and first jobs happen costs more than the time taken. In the largest cohort, 23 per cent of childhood cancer survivors had used special education services against 8 per cent of siblings, and survivors of several cancers were less likely to finish high school. The important finding is that where the educational support was given, the gap closed."@en ;
  schema:url <https://onco.cc/technologies/rejuv-ayac-education-and-work/> ;
  schema:dateModified "2026-10-02"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Cancer_survivor> ;
  schema:citation <https://doi.org/10.1002/cncr.11117>, <https://doi.org/10.1200/JCO.2012.48.2315>, <https://doi.org/10.3322/caac.21585>, <https://www.ighg.org/guidelines/> ;
  onco:status "established" ;
  onco:tag "rejuvenation", "survivorship", "paediatric", "late-effects", "evidence:moderate" ;
  onco:related <https://onco.cc/trials/ccss/>, <https://onco.cc/collections/sjlife/>, <https://onco.cc/collections/ighg/> ;
  onco:cancers <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/childhood-cancers/>, <https://onco.cc/cancers/medulloblastoma/>, <https://onco.cc/cancers/paediatric-low-grade-glioma/>, <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/neuroblastoma/> ;
  onco:sections <https://onco.cc/fronts/rejuvenation/>, <https://onco.cc/fronts/supportive-care/> ;
  onco:technologies <https://onco.cc/technologies/rejuv-paed-neurocognitive/>, <https://onco.cc/technologies/cognitive-impairment-after-cancer-treatment/>, <https://onco.cc/technologies/rejuv-ayac-distinct-group/>, <https://onco.cc/technologies/rejuv-ayac-services/>, <https://onco.cc/technologies/survivorship-care-plan/> ;
  onco:drugs <https://onco.cc/drugs/methotrexate/> ;
  onco:terms <https://onco.cc/terms/late-effects/>, <https://onco.cc/terms/quality-of-life/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-survivorship/>, <https://onco.cc/bottlenecks/b-toxicity-qol/> .